Evidence text
Paper-level observation
Section 3.9: In C57BL/6J mice model, the 72-h survival rate of the MR-22 group was 40%.
textConfidence: medium
Assay observation
Source publication
The antibacterial activity and mechanism of a novel peptide MR-22 against multidrug-resistant Escherichia coli.
Frontiers in Cellular and Infection Microbiology · 2024
Related peptide identities
Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.
